Expression of IGFBP‑6 in proliferative vitreoretinopathy rat models and its effects on retinal pigment epithelial‑J cells

Zhu,Wei; Wu,Yan; Cui,Chen; Zhao,Hong‑Mei; Ba,Jun; Chen,Hui; Yu,Jing

doi:10.3892/mmr.2013.1794

Expression of IGFBP‑6 in proliferative vitreoretinopathy rat models and its effects on retinal pigment epithelial‑J cells

Authors:
- Wei Zhu
- Yan Wu
- Chen Cui
- Hong‑Mei Zhao
- Jun Ba
- Hui Chen
- Jing Yu
View Affiliations

Affiliations: Department of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China, Department of Ophthalmology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China
Published online on: November 12, 2013 https://doi.org/10.3892/mmr.2013.1794
Pages: 33-38

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Proliferative vitreoretinopathy (PVR) is one of the most common causes for failed retinal detachment surgeries. The aim of the present study was to investigate the role of insulin‑like growth factor‑binding protein‑6 (IGFBP‑6) in PVR using rat models and its effects on retinal pigment epithelial‑J (RPE‑J) cells. PVR Wistar rat models were administered intravitreal injection of RPE‑J cells (1x106/5 µl) combined with platelet‑rich plasma (1x107/5 µl). The concentration of IGFBP‑6 in the vitreous and serum of rats was tested by an enzyme‑linked immunosorbent assay and the expression of IGFBP‑6 mRNA in the liver and retina of rats was determined by quantitative polymerase chain reaction (qPCR). The expression of IGFBP‑6 mRNA in the RPE‑J cells stimulated by vitreous or serum from PVR patients or normal volunteers was also determined by qPCR. The proliferation of RPE‑J cells was evaluated by the 3‑(4,5‑dimethylthiazol‑2‑yl)‑5‑(3‑carboxymethoxyphenyl)‑2‑(4‑sulfophenyl)‑2H‑tetrazolium, inner salt (MTS) method. The success rate of PVR rat model induction at the 8th week was 89.5% (34/38). The concentration of IGFBP‑6 in the vitreous and serum of PVR rats was significantly higher than that of the control group (P<0.05). The expression of IGFBP‑6 mRNA in the retina of PVR rats was also significantly higher compared with the control group (P<0.05). The vitreous from PVR patients and donors significantly stimulated the expression of IGFBP‑6 mRNA in the RPE‑J cells (P<0.05). IGFBP‑6 only inhibited IGF‑II‑stimulated proliferation but not the basal level of proliferation or the PDGF/VEGF‑stimulated RPE‑J cell proliferation. Thus, the trends and effects of IGFBP‑6 provide the possibility of PVR therapeutic targets, with the vitreous representing a significant environmental factor in the progression of PVR.

View Figures

View References

1	Pastor JC: Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 43:3–18. 1998. View Article : Google Scholar : PubMed/NCBI
2	Weller M, Wiedemann P and Heimann K: Proliferative vitreoretinopathy - is it anything more than wound healing at the wrong place? Int Ophthalmol. 14:105–117. 1990. View Article : Google Scholar : PubMed/NCBI
3	Girard P, Mimoun G, Karpouzas I and Montefiore G: Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina. 14:417–424. 1994. View Article : Google Scholar : PubMed/NCBI
4	Pastor JC, de la Rúa ER and Martín F: Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 21:127–144. 2002. View Article : Google Scholar : PubMed/NCBI
5	Ryan SJ: The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol. 100:188–193. 1985. View Article : Google Scholar : PubMed/NCBI
6	Wiedemann P and Weller M: The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol Suppl. 189:3–15. 1988.
7	Baudouin C, Hofman P, Brignole F, Bayle J, Loubière R and Gastaud P: Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy. Ophthalmologica. 203:38–46. 1991. View Article : Google Scholar
8	Vinores SA, Campochiaro PA and Conway BP: Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 31:14–28. 1990.PubMed/NCBI
9	Wong CA, Potter MJ, Cui JZ, et al: Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells. Can J Ophthalmol. 37:211–220. 2002. View Article : Google Scholar : PubMed/NCBI
10	Yang CH, Huang TF, Liu KR, Chen MS and Hung PT: Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. Invest Ophthalmol Vis Sci. 37:843–854. 1996.PubMed/NCBI
11	Mukherjee S and Guidry C: The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation. Invest Ophthalmol Vis Sci. 48:1892–1899. 2007. View Article : Google Scholar : PubMed/NCBI
12	Spraul CW, Kaven C, Amann J, Lang GK and Lang GE: Effect of insulin-like growth factors 1 and 2, and glucose on the migration and proliferation of bovine retinal pigment epithelial cells in vitro. Ophthalmic Res. 32:244–248. 2000. View Article : Google Scholar : PubMed/NCBI
13	Mitsuhiro MR, Eguchi S and Yamashita H: Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily. Acta Ophthalmol Scand. 81:630–638. 2003. View Article : Google Scholar : PubMed/NCBI
14	Spraul CW, Kaven C, Lang GK and Lang GE: Effect of growth factors on bovine retinal pigment epithelial cell migration and proliferation. Ophthalmic Res. 36:166–171. 2004. View Article : Google Scholar : PubMed/NCBI
15	Hollborn M, Bringmann A, Faude F, Wiedemann P and Kohen L: Signaling pathways involved in PDGF-evoked cellular responses in human RPE cells. Biochem Biophys Res Commun. 344:912–919. 2006. View Article : Google Scholar : PubMed/NCBI
16	Yu J, Liu F, Cui SJ, et al: Vitreous proteomic analysis of proliferative vitreoretinopathy. Proteomics. 8:3667–3678. 2008. View Article : Google Scholar : PubMed/NCBI
17	Zheng XZ, Du LF and Wang HP: An immunohistochemical analysis of a rat model of proliferative vitreoretinopathy and a comparison of the expression of TGF-β and PDGF among the induction methods. Bosn J Basic Med Sci. 10:204–209. 2010.PubMed/NCBI
18	Behar-Cohen FF, Thillaye-Goldenberg B, de Bizemont T, Savoldelli M, Chauvaud D and de Kozak Y: EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR. Invest Ophthalmol Vis Sci. 41:3915–3924. 2000.PubMed/NCBI
19	No authors listed. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 90:121–125. 1983. View Article : Google Scholar : PubMed/NCBI
20	Yanyali A and Bonnet M: Risk factors of postoperative proliferative vitreoretinopathy in giant tears. J Fr Ophtalmol. 19:175–180. 1996.(In French).
21	Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3–34. 1995.PubMed/NCBI
22	Burren CP, Berka JL, Edmondson SR, Werther GA and Batch JA: Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye. Invest Ophthalmol Vis Sci. 37:1459–1468. 1996.PubMed/NCBI
23	Bergman PB, Moravski CJ, Edmondson SR, et al: Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye. Invest Ophthalmol Vis Sci. 46:2708–2715. 2005. View Article : Google Scholar : PubMed/NCBI
24	Gallicchio MA, Kaun C, Wojta J, Binder B and Bach LA: Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro. J Cell Physiol. 197:131–138. 2003. View Article : Google Scholar : PubMed/NCBI
25	Gallicchio MA, Kneen M, Hall C, Scott AM and Bach LA: Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int J Cancer. 94:645–651. 2001. View Article : Google Scholar : PubMed/NCBI
26	Bach LA: Insulin-like growth factor binding protein-6: the ‘forgotten’ binding protein? Horm Metab Res. 31:226–234. 1999.
27	Chaves J and Saif MW: IGF system in cancer: from bench to clinic. Anticancer Drugs. 22:206–212. 2011. View Article : Google Scholar : PubMed/NCBI
28	Kuo YS, Tang YB, Lu TY, Wu HC and Lin CT: IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression. J Pathol. 222:299–309. 2010. View Article : Google Scholar : PubMed/NCBI
29	Seurin D, Lassarre C, Bienvenu G and Babajko S: Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development. Eur J Cancer. 38:2058–2065. 2002. View Article : Google Scholar : PubMed/NCBI
30	Leng SL, Leeding KS, Whitehead RH and Bach LA: Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells. Mol Cell Endocrinol. 174:121–127. 2001. View Article : Google Scholar : PubMed/NCBI
31	Ricker LJ, Kijlstra A, Kessels AG, et al: Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS One. 6:e191412011. View Article : Google Scholar : PubMed/NCBI
32	Pennock S and Kazlauskas A: Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses. Mol Cell Biol. 32:1955–1966. 2012. View Article : Google Scholar
33	Ricker LJ, Dieudonné SC, Kessels AG, et al: Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Retina. 32:54–59. 2012. View Article : Google Scholar
34	Liang CM, Tai MC, Chang YH, et al: Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy. Acta Ophthalmol. 89:e505–e514. 2011. View Article : Google Scholar
35	Karthikeyan B, Kalishwaralal K, Sheikpranbabu S, Deepak V, Haribalaganesh R and Gurunathan S: Gold nanoparticles downregulate VEGF-and IL-1β-induced cell proliferation through Src kinase in retinal pigment epithelial cells. Exp Eye Res. 91:769–778. 2010.PubMed/NCBI
36	Parrales A, López E and López-Colomé AM: Thrombin activation of PI3K/PDK1/Akt signaling promotes cyclin D1 upregulation and RPE cell proliferation. Biochim Biophys Acta. 1813:1758–1766. 2011. View Article : Google Scholar : PubMed/NCBI